Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2433600rdf:typepubmed:Citationlld:pubmed
pubmed-article:2433600lifeskim:mentionsumls-concept:C0521390lld:lifeskim
pubmed-article:2433600lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:2433600lifeskim:mentionsumls-concept:C0060608lld:lifeskim
pubmed-article:2433600lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:2433600lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:2433600lifeskim:mentionsumls-concept:C0439799lld:lifeskim
pubmed-article:2433600lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:2433600lifeskim:mentionsumls-concept:C1882151lld:lifeskim
pubmed-article:2433600pubmed:issue7000lld:pubmed
pubmed-article:2433600pubmed:dateCreated1987-2-25lld:pubmed
pubmed-article:2433600pubmed:abstractTextNeurotransmitters modulate the activity of ion channels through a variety of second messengers, including cyclic AMP, cyclic GMP and the products of phosphatidylinositol breakdown. Little is known about how different transmitters acting through different second-messenger systems interact within a cell to regulate single ion channels. We here describe the reciprocal actions of serotonin and the molluscan neuropeptide, FMRFamide, on individual K+ channels in Aplysia sensory neurons. In these cells, serotonin causes prolonged all-or-none closure of a class of background conductance K+ channels (the S channels) through cAMP-dependent protein phosphorylation. Using single-channel recording, we have found that FMRFamide produces two actions on the S channels; it increases the probability of opening of the S channels via a cAMP-independent second-messenger system and it reverses the closures of S channels produced by serotonin or cAMP.lld:pubmed
pubmed-article:2433600pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2433600pubmed:languageenglld:pubmed
pubmed-article:2433600pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2433600pubmed:citationSubsetIMlld:pubmed
pubmed-article:2433600pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2433600pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2433600pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2433600pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2433600pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2433600pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2433600pubmed:statusMEDLINElld:pubmed
pubmed-article:2433600pubmed:issn0028-0836lld:pubmed
pubmed-article:2433600pubmed:authorpubmed-author:KandelE RERlld:pubmed
pubmed-article:2433600pubmed:authorpubmed-author:BelardettiFFlld:pubmed
pubmed-article:2433600pubmed:authorpubmed-author:SiegelbaumS...lld:pubmed
pubmed-article:2433600pubmed:issnTypePrintlld:pubmed
pubmed-article:2433600pubmed:volume325lld:pubmed
pubmed-article:2433600pubmed:ownerNLMlld:pubmed
pubmed-article:2433600pubmed:authorsCompleteYlld:pubmed
pubmed-article:2433600pubmed:pagination153-6lld:pubmed
pubmed-article:2433600pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2433600pubmed:meshHeadingpubmed-meshheading:2433600-...lld:pubmed
pubmed-article:2433600pubmed:meshHeadingpubmed-meshheading:2433600-...lld:pubmed
pubmed-article:2433600pubmed:meshHeadingpubmed-meshheading:2433600-...lld:pubmed
pubmed-article:2433600pubmed:meshHeadingpubmed-meshheading:2433600-...lld:pubmed
pubmed-article:2433600pubmed:meshHeadingpubmed-meshheading:2433600-...lld:pubmed
pubmed-article:2433600pubmed:meshHeadingpubmed-meshheading:2433600-...lld:pubmed
pubmed-article:2433600pubmed:meshHeadingpubmed-meshheading:2433600-...lld:pubmed
pubmed-article:2433600pubmed:meshHeadingpubmed-meshheading:2433600-...lld:pubmed
pubmed-article:2433600pubmed:meshHeadingpubmed-meshheading:2433600-...lld:pubmed
pubmed-article:2433600pubmed:meshHeadingpubmed-meshheading:2433600-...lld:pubmed
pubmed-article:2433600pubmed:meshHeadingpubmed-meshheading:2433600-...lld:pubmed
pubmed-article:2433600pubmed:meshHeadingpubmed-meshheading:2433600-...lld:pubmed
pubmed-article:2433600pubmed:meshHeadingpubmed-meshheading:2433600-...lld:pubmed
pubmed-article:2433600pubmed:articleTitleNeuronal inhibition by the peptide FMRFamide involves opening of S K+ channels.lld:pubmed
pubmed-article:2433600pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2433600pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2433600pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2433600lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2433600lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2433600lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2433600lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2433600lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2433600lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2433600lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2433600lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2433600lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2433600lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2433600lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2433600lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2433600lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2433600lld:pubmed